← Who reports today · Health Care
RMD earnings date & Q4 FY2026 results · ResMed
US GAAP · $M · vs Q4 FY2025 · quarter ended 06/30/2026 (fiscal year is shifted) · reported 08/06/2026
ResMed — Resmed Inc. is a medical equipment company based in San Diego, California, and founded in Australia. · Text: Wikipedia, CC BY-SA 4.0, abridged
More about the company
It primarily provides cloud-connectable medical devices for the treatment of sleep apnea, chronic obstructive pulmonary disease (COPD), and other respiratory conditions. Resmed produced hundreds of thousands of ventilators and bilevel devices to help treat the respiratory symptoms of patients with COVID-19. Resmed also provides software to out-of-hospital care agencies to streamline transitions of care into and between these care settings for seniors and their care providers.
Key growth driver: Revenue growth of +9% y/y — the report gives no segment split, so the driver is the whole business. · by the Q4 FY2026 report
When is RMD’s next earnings date?
Thursday, October 29, 2026estimated
Expected around Oct 29 — based on last year’s report on Oct 30, 2025. We have not yet seen the company's announcement of the date.
How we estimate
The estimate is the date of the same-quarter report a year ago, per the company’s SEC filing, moved forward 52 weeks (same weekday). Companies usually keep the same week; the date will be replaced once RMD announces it.
Same quarter a year ago (ended September 30, 2025): revenue $1.336B, EPS (GAAP) $2.37
How we calculate
Year-ago figures are GAAP, from the company's SEC filings (XBRL); EPS is diluted.
What time does RMD report? Usually after market close: the last 4 results releases reached the SEC at 4:05 pm, 5:24 pm, 4:06 pm, 4:05 pm ET.
Last report: Aug 6, 2026 (Q4 FY2026) — broken down in the Sankey chart below. Dates: company announcements; past dates and times — SEC 8-K filings. Who else reports this week →
All figures in $M.
Revenue
$1,464
+8.6%
Gross profit
$861
+5.0%
58.8% margin
Operating income
$449
−1.3%
30.7% margin
Net income
$383
+1.0%
$2.64/sh · 26.2% margin
Verdict: revenue grew 8.6% y/y to $1.46B, operating margin 30.7% vs 33.7%, net income $383M (+1.0% y/y).
Resmed announced a 10% increase in its quarterly dividend to $0.66 per share.
Source and notation
Source: ResMed press release, 8-K EX-99.1 of 08/06/2026 (SEC EDGAR). Every figure was matched against the income statement in the release and checked against SEC XBRL.
Open the chart as a PNG image ↗ · for sharing and presentations · free to reuse, CC BY 4.0
RMD earnings history: past report dates
| Jul 7, 2026 Tue | 5:24 pmafter market close | Jun 30, 2026 | ≈$1.5B+9% y/y | ≈$2.64+2% y/y |
| Apr 30, 2026 Thu | 4:06 pmafter market close | Mar 31, 2026 | $1.4B+11% y/y | $2.74+10% y/y |
| Jan 29, 2026 Thu | 4:05 pmafter market close | Dec 31, 2025 | $1.4B+11% y/y | $2.68+15% y/y |
| Oct 30, 2025 Thu | 4:06 pmafter market close | Sep 30, 2025 | $1.3B+9% y/y | $2.37+12% y/y |
| Jul 31, 2025 Thu | 4:05 pmafter market close | Jun 30, 2025 | ≈$1.3B+10% y/y | ≈$2.58+31% y/y |
| Apr 23, 2025 Wed | 4:05 pmafter market close | Mar 31, 2025 | $1.3B+8% y/y | $2.48+22% y/y |
| Jan 30, 2025 Thu | 4:05 pmafter market close | Dec 31, 2024 | $1.3B+10% y/y | $2.34+65% y/y |
| Oct 24, 2024 Thu | 4:05 pmafter market close | Sep 30, 2024 | $1.2B+11% y/y | $2.11+42% y/y |
| Aug 1, 2024 Thu | 4:05 pmafter market close | Jun 30, 2024 | ≈$1.2B+9% y/y | ≈$1.97+26% y/y |
| Apr 25, 2024 Thu | 4:07 pmafter market close | Mar 31, 2024 | $1.2B+7% y/y | $2.04+29% y/y |
| Jan 24, 2024 Wed | 4:06 pmafter market close | Dec 31, 2023 | $1.2B+12% y/y | $1.42−7% y/y |
| Oct 26, 2023 Thu | 4:05 pmafter market close | Sep 30, 2023 | $1.1B+16% y/y | $1.49+4% y/y |
| Aug 3, 2023 Thu | 4:06 pmafter market close | Jun 30, 2023 | ≈$1.1B+23% y/y | ≈$1.56+17% y/y |
| Apr 27, 2023 Thu | 4:06 pmafter market close | Mar 31, 2023 | $1.1B+29% y/y | $1.58+30% y/y |
| Jan 26, 2023 Thu | 4:05 pmafter market close | Dec 31, 2022 | $1.0B+16% y/y | $1.53+12% y/y |
| Oct 27, 2022 Thu | 4:05 pmafter market close | Sep 30, 2022 | $950M+5% y/y | $1.43+3% y/y |
| Aug 11, 2022 Thu | 4:07 pmafter market close | Jun 30, 2022 | ≈$915M+4% y/y | ≈$1.33+0% y/y |
| Apr 28, 2022 Thu | 4:07 pmafter market close | Mar 31, 2022 | $865M+12% y/y | $1.22 |
| Jan 27, 2022 Thu | 4:06 pmafter market close | Dec 31, 2021 | $895M+12% y/y | $1.37+11% y/y |
| Oct 28, 2021 Thu | 4:07 pmafter market close | Sep 30, 2021 | $904M+20% y/y | $1.39+14% y/y |
| Aug 5, 2021 Thu | 4:08 pmafter market close | Jun 30, 2021 | ≈$876M+14% y/y | ≈$1.33+9% y/y |
| Apr 29, 2021 Thu | 4:06 pmafter market close | Mar 31, 2021 | $769M−0% y/y | −$0.54 |
| Jan 28, 2021 Thu | 4:05 pmafter market close | Dec 31, 2020 | $800M+9% y/y | $1.23+12% y/y |
| Oct 29, 2020 Thu | 4:05 pmafter market close | Sep 30, 2020 | $752M+10% y/y | $1.22+47% y/y |
| Aug 5, 2020 Wed | 4:05 pmafter market close | Jun 30, 2020 | ≈$770M+9% y/y | ≈$1.22+160% y/y |
| Apr 30, 2020 Thu | 4:05 pmafter market close | Mar 31, 2020 | $769M+16% y/y | $1.12+53% y/y |
| Jan 30, 2020 Thu | 4:05 pmafter market close | Dec 31, 2019 | $736M+13% y/y | $1.10+28% y/y |
| Oct 24, 2019 Thu | 4:05 pmafter market close | Sep 30, 2019 | $681M+16% y/y | $0.83+14% y/y |
| Jul 25, 2019 Thu | 4:05 pmafter market close | Jun 30, 2019 | ≈$705M+13% y/y | ≈$0.47−38% y/y |
| May 2, 2019 Thu | 4:06 pmafter market close | Mar 31, 2019 | $662M+12% y/y | $0.73−4% y/y |
| Jan 24, 2019 Thu | 4:05 pmafter market close | Dec 31, 2018 | $651M+8% y/y | $0.86 |
| Oct 25, 2018 Thu | 4:05 pmafter market close | Sep 30, 2018 | $588M+12% y/y | $0.73+22% y/y |
| Aug 2, 2018 Thu | 4:06 pmafter market close | Jun 30, 2018 | ≈$624M+12% y/y | ≈$0.76+7% y/y |
| Apr 26, 2018 Thu | 4:06 pmafter market close | Mar 31, 2018 | $592M+15% y/y | $0.76+23% y/y |
| Jan 22, 2018 Mon | 4:05 pmafter market close | Dec 31, 2017 | $601M+13% y/y | $0.07−87% y/y |
| Oct 26, 2017 Thu | 4:06 pmafter market close | Sep 30, 2017 | $524M+13% y/y | $0.60+11% y/y |
| Aug 1, 2017 Tue | 4:10 pmafter market close | Jun 30, 2017 | ≈$557M+7% y/y | ≈$0.71+20% y/y |
| Apr 27, 2017 Thu | 4:05 pmafter market close | Mar 31, 2017 | $514M+13% y/y | $0.62−3% y/y |
| Jan 23, 2017 Mon | 4:05 pmafter market close | Dec 31, 2016 | $530M+17% y/y | $0.54−21% y/y |
| Oct 25, 2016 Tue | 4:05 pmafter market close | Sep 30, 2016 | $465M+13% y/y | $0.54−7% y/y |
| Jul 28, 2016 Thu | 4:05 pmafter market close | Jun 30, 2016 | ≈$519M+14% y/y | ≈$0.59−3% y/y |
| Apr 26, 2016 Tue | 4:05 pmafter market close | Mar 31, 2016 | $454M+7% y/y | $0.64+0% y/y |
| Jan 21, 2016 Thu | 4:05 pmafter market close | Dec 31, 2015 | $455M+7% y/y | $0.68+6% y/y |
| Oct 22, 2015 Thu | 4:05 pmafter market close | Sep 30, 2015 | $412M+8% y/y | $0.58+0% y/y |
| Jul 30, 2015 Thu | 4:05 pmafter market close | Jun 30, 2015 | ≈$453M+9% y/y | ≈$0.61+0% y/y |
| Apr 23, 2015 Thu | 4:05 pmafter market close | Mar 31, 2015 | $422M+6% y/y | $0.64+2% y/y |
| Jan 22, 2015 Thu | 4:05 pmafter market close | Dec 31, 2014 | $423M+10% y/y | $0.64+7% y/y |
| Oct 23, 2014 Thu | 4:05 pmafter market close | Sep 30, 2014 | $380M+6% y/y | $0.58+4% y/y |
| Jul 31, 2014 Thu | 4:06 pmafter market close | Jun 30, 2014 | ≈$415M+0% y/y | ≈$0.61+22% y/y |
| Apr 23, 2014 Wed | 4:06 pmafter market close | Mar 31, 2014 | $398M+4% y/y | $0.63+9% y/y |
| Jan 23, 2014 Thu | 4:05 pmafter market close | Dec 31, 2013 | $384M+2% y/y | $0.60+13% y/y |
| Oct 24, 2013 Thu | 4:06 pmafter market close | Sep 30, 2013 | $358M+5% y/y | $0.56+14% y/y |
| Aug 1, 2013 Thu | 4:05 pmafter market close | Jun 30, 2013 | ≈$415M+11% y/y | ≈$0.50−6% y/y |
| Apr 25, 2013 Thu | 4:05 pmafter market close | Mar 31, 2013 | $384M+10% y/y | $0.58+32% y/y |
| Jan 24, 2013 Thu | 4:08 pmafter market close | Dec 31, 2012 | $377M+13% y/y | $0.53+26% y/y |
| Oct 25, 2012 Thu | 4:05 pmafter market close | Sep 30, 2012 | $340M+8% y/y | $0.49+48% y/y |
| Aug 2, 2012 Thu | 4:06 pmafter market close | Jun 30, 2012 | ≈$372M+9% y/y | ≈$0.53+43% y/y |
| Apr 26, 2012 Thu | 4:05 pmafter market close | Mar 31, 2012 | $349M+11% y/y | $0.44+29% y/y |
| Jan 26, 2012 Thu | 4:05 pmafter market close | Dec 31, 2011 | $333M | $0.42 |
| Oct 24, 2011 Mon | 4:05 pmafter market close | Sep 30, 2011 | $315M | $0.33 |
| Aug 4, 2011 Thu | 4:05 pmafter market close | Jun 30, 2011 | ≈$342M | ≈$0.37 |
| Apr 28, 2011 Thu | 4:07 pmafter market close | Mar 31, 2011 | $313M | $0.34 |
Show all 62 reports since 2011Show fewer
How we count
Report date and time — when the company filed its results press release with the SEC (Form 8-K, Item 2.02); the regular session runs 9:30 am – 4:00 pm ET. Companies that file the 8-K late in the evening publish the release the next morning: the date is that morning, before market open, and the evening filing time is not shown. Revenue and diluted EPS — the company’s XBRL filings, EPS adjusted for stock splits; ≈ — fourth quarter derived as full year minus three quarters. Source: SEC EDGAR.
ResMed: 16-year financials
| FY2026 | 5,653 | 1,887 | 1,523 | 1,650 | 350 |
| FY2025 | 5,146 | 1,685 | 1,401 | 1,662 | 311 |
| FY2024 | 4,685 | 1,320 | 1,021 | 1,302 | 282 |
| FY2023 | 4,223 | 1,132 | 898 | 574 | 258 |
| FY2022 | 3,578 | 1,000 | 779 | 216 | 245 |
| FY2021 | 3,197 | 904 | 475 | 634 | 227 |
| FY2020 | 2,957 | 810 | 622 | 707 | 225 |
| FY2019 | 2,607 | 579 | 405 | 390 | 212 |
| FY2018 | 2,340 | 542 | 316 | 442 | 200 |
| FY2017 | 2,067 | 426 | 342 | 352 | 186 |
| FY2016 | 1,839 | 429 | 352 | 489 | 168 |
| FY2015 | 1,679 | 409 | 353 | 321 | 157 |
| FY2014 | 1,555 | 405 | 345 | 319 | 142 |
| FY2013 | 1,515 | 355 | 307 | 339 | 97.2 |
| FY2012 | 1,369 | 294 | 255 | 336 | — |
| FY2011 | 1,243 | 267 | 227 | 217 | — |
Show all 16 yearsShow fewer
$ millions, annual 10-K reports on SEC EDGAR (US GAAP)*; the company’s fiscal year doesn’t match the calendar year so years follow the company’s own labels.
How we calculate
Figures are annual report lines; if a year was later restated (discontinued operations, mergers), we use the latest filing that shows it. Free cash flow is operating cash flow minus capital expenditures; dividends are cash paid to common shareholders during the year. “—” means the line isn’t in the filing. The table starts in 2011; where the listed issuer changed (holding reorganization, redomicile), earlier years come from the predecessor’s filings.
Shareholders’ equity at Jun 30, 2026: $6.6B (73% of total assets). Compare with other S&P 500 companies →
Included in screener lists: S&P 500 companies with revenue growth 10 years in a row · S&P 500 companies with no net debt · S&P 500 companies that paid dividends 10 years without a gap
ResMed (RMD) earnings: FAQ
When is RMD's next earnings date?
We have not yet seen an announcement of the date from ResMed (RMD). Based on last year's report on Oct 30, 2025, the next report is expected around Oct 29, 2026.
What time does RMD report earnings?
ResMed usually reports after market close: its latest results release was filed with the SEC at 4:05 pm ET on Aug 6, 2026.
When did RMD last report earnings?
ResMed reported Q4 FY2026 results on Aug 6, 2026.
Where can I find ResMed's financial statements?
On SEC EDGAR: quarterly reports (10-Q), the annual report (10-K) and earnings releases (8-K). The “Verified” badge next to the chart links to RMD's filings; this page breaks the latest report down in a Sankey chart.
What was RMD's net income in Q4 FY2026?
ResMed reported net income of $383M for Q4 FY2026 (+1.0% year over year), under US GAAP.
Does ResMed pay dividends?
Yes. In fiscal 2026, ResMed paid $350M in dividends on its common stock, per its 10-K. Earlier years are in the 16-year table above.
How has ResMed's revenue changed since 2011?
Per its 10-K filings, revenue grew 4.5x: $1,243M in fiscal 2011 and $5,653M in fiscal 2026. The latest year is the highest in the table. Year-by-year figures are in the table above.
New to earnings reports? Start with how to read an earnings report.
How this page was made: the figures come from the company's own report on SEC EDGAR; the summary and nuances were drafted by our model from that report — two independent automated readings of the release had to match, and every number in the text was checked against it. Figures checked against the filing on 10/16/2026. How we make the breakdowns · Report an error
More reports: SOLV · Q2 2026 · STE · Q1 FY2027 · SYK · Q2 2026 · TECH · Q4 FY2026 · TMO · Q2 2026 · UHS · Q2 2026 · UNH · Q3 2026 · VEEV · Q2 FY2027 · VRTX · Q2 2026 · ZBH · Q2 2026 · all reports